MMP-7 (- 181A > G) promoter polymorphisms and risk for cervical cancer

Gynecologic Oncology

Volumn 110, Issue 1, 2008, Pages 71-75

  Singh, HariOm ^a   Jain, Meenu ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Genetic susceptibility; Matrix metalloproteinase; Polymorphism

Indexed keywords

GENOMIC DNA; MATRILYSIN;

ADULT; ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANCER RISK; CANCER STAGING; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROL GROUP; CYTOLOGY; DNA EXTRACTION; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK; SMOKING; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; UTERINE CERVIX CANCER;

FEMALE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 7; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 45549084956     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.03.007     Document Type: Article

References (34)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 2 (2001) 153-156
2. Sankaranarayanan R., Nene B.M., Dinshaw K., Rajkumar R., Shastri S., Wesley R., et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica de Mexico 45 Supp.12 (2003) S274-S282
3. Farzaneh F., Roberts S., Mandal D., Ollier B., Winters U., Kitchener H.C., et al. The IL-10 -1082G polymorphism is associated with clearance of HPV infection. BJOG 113 8 (2006) 961-964
4. Woessner Jr. J.F., and Taplin C. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263 32 (1988) 16918-16925
5. Miyazaki K., Hattori Y., Umenishi F., Yasumitsu H., and Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50 24 (1990) 7758-7764
6. Wilson C.L., and Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28 2 (1996) 123-136
7. Muller D., Breathnach R., Engelmann A., Millon R., Bronner G., Flesch H., et al. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48 4 (1991) 550-556
8. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 6303 (1990) 699-704
9. Pajouh M.S., Nagle R.B., Breathmach R., Finch J.S., Brawer M.K., and Bowden G.T. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117 2 (1991) 144-150
10. Jones L.E., Humphreys M.J., Campbell F., Neoptolemos J.P., and Boyd M.T. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 10 8 (2004) 2832-2845
11. Jormsjö S., Whatling C., Dirk H., Walter, Andreas M., Zeiher, et al. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21 11 (2001) 1834-1839
12. Ghilardi G., Biondi M.L., Erario M., Guagnellini E., and Scorza1 R. Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 49 11 (2003) 1940-1942
13. Hellmig S., Ott S., Rosenstiel P., Robert U.F., Hampe J., and Schreiber S. Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. pylori infection. Am J Gastroenterol 101 1 (2006) 29-35
14. Zhang J., Jin X., fang S., Wang R., li Y., Wang N., et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26 10 (2005) 1748-1753
15. Li Y., Jin X., Kang S., Wang Y., Du H., Zhang J., et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 101 1 (2006) 92-96
16. Vairaktaris E., Serefoglou Z., Yapijakis C., Vylliotis A., Nkenke E., Derka S., et al. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res 27 4B (2007) 2493-2498
17. Wu S.H., Zhang J., Li Y., and Li J.M. Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis. Ai Zheng 25 3 (2006) 315-319
18. Shepperd J.H. FIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 5 5 (1995) 319
19. Miller S.A., Dykes D.D., and Polesky H.F. A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res 16 3 (1998) 1215
20. Jormsjö S., Whatling C., Dirk H., Walter, Andreas M., Zeiher, et al. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21 11 (2001) 1834-1839
21. Yoshida H., Sumi T., Hyun Y., Nakagawa E., Hattori K., Yasui T., et al. Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncol Rep 10 1 (2003) 45-49
22. Masanori I., Yamamoto H., Adachi V., Maruyama Y., and Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231 1 (2006) 20-27
23. Saarialho-Kere U.K., Crouch E.C., and Parks W.C. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 105 2 (1995) 190-196
24. Yu W.H., Woessner J.F.J., McNeish J.D., and Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16 3 (2002) 307-323
25. Holler N., Tardivel A., Kovacsovics-Bankowski M., Hertig S., Gaide O., Martinon F., et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 23 4 (2003) 1428-1440
26. Barille S., Bataille R., Rapp M.J., Harousseau J.L., and Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol 163 10 (1999) 5723-5728
27. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 3 (2002) 161-174
28. Lu Z., Wang Y., Zhang Q., Zhang X., Wang S., Xie H., et al. Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma. Brain Res 1118 1 (2006) 6-12
29. Hellberg D., Nilsson S., Haley N.J., Hoffman D., and Wynder E. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 158 4 (1988) 910-913
30. Sedlacek T.V. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 42 2 (1999) 206-220
31. Kataja V., Syrjänen S., Yliskoski M., Hippelïnen M., Väyrynen M., Saarikoski S., et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 138 9 (1993) 735-745
32. Trimble C.L., Genkinger J.M., Burke A.E., Hoffman S.C., Helzlsouer K.J., West M.D., et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 105 1 (2005) 174-181
33. Yu C., Pan K., Xing D., Liang G., Tan W., Zhang L., et al. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62 15 (2002) 6430-6433
34. Lahmann C., Bergemann J., Harrison G., and Young A.R. Matrix metalloproteinase-1 and skin ageing in smokers. Lancet 357 9260 (2001) 935-936